Hiroshi Kida

4.8k total citations
173 papers, 3.0k citations indexed

About

Hiroshi Kida is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Nephrology. According to data from OpenAlex, Hiroshi Kida has authored 173 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Pulmonary and Respiratory Medicine, 38 papers in Epidemiology and 31 papers in Nephrology. Recurrent topics in Hiroshi Kida's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (29 papers), Renal Diseases and Glomerulopathies (29 papers) and Mycobacterium research and diagnosis (20 papers). Hiroshi Kida is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (29 papers), Renal Diseases and Glomerulopathies (29 papers) and Mycobacterium research and diagnosis (20 papers). Hiroshi Kida collaborates with scholars based in Japan, United States and United Kingdom. Hiroshi Kida's co-authors include Isao Tachibana, Hitoshi Yokoyama, Atsushi Kumanogoh, Yoshito Takeda, Nobutaka Hattori, Sho Goya, Ichiro Kawase, Izumi Nagatomo, Tadashi Osaki and Masahide Mori and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Hiroshi Kida

163 papers receiving 2.9k citations

Peers

Countries citing papers authored by Hiroshi Kida

Since Specialization

Citations

This map shows the geographic impact of Hiroshi Kida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Kida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Kida more than expected).

Fields of papers citing papers by Hiroshi Kida

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshi Kida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Kida. The network helps show where Hiroshi Kida may publish in the future.

Co-authorship network of co-authors of Hiroshi Kida

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Kida. A scholar is included among the top collaborators of Hiroshi Kida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Kida. Hiroshi Kida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Predictors of Exacerbation of Japanese Bronchiectasis and Nontuberculous Mycobacterial Pulmonary Disease: A Multicenter Prospective Study 2025 ·American Journal of Respiratory and Critical Care Medicine ·Taijiro Ozawa, Takanori Asakura, Kozo Morimoto, Akihiro Ito, Hideo Tanaka, Hong Namkoong, Eriko Morino, Taku Nakagawa, Toru Kadowaki, (unknown), Hirofumi Kamata, Isano Hase, (unknown), Hiroki Tateno, Yoshitaka Oyamada, Masaki Fujita, Hiroshi Kida, Makoto Ishii, (unknown), (unknown)	0
2	Identification of α-galactosylceramide as an endogenous mammalian antigen for iNKT cells 2024 ·The Journal of Experimental Medicine ·Yuki Hosono, (unknown), (unknown), Eri Ishikawa, Masatomo Takahashi, Akihiro Imamura, Hideharu Ishida, Federica Compostella, Hiroshi Kida, Atsushi Kumanogoh, Takeshi Bamba, Yoshihiro Izumi, Sho Yamasaki	5
3	Anti-Myxovirus Resistance Protein-1 Immunoglobulin A Autoantibody in Idiopathic Pulmonary Fibrosis 2022 ·Canadian Respiratory Journal ·Toru Arai, Masaki Hirose, (unknown), Tomoko Kagawa, Akihiro Murakami, Hiroshi Kida, Atsushi Kumanogoh, Yoshikazu Inoue	3
4	Prognostic significance of serum cytokines during acute exacerbation of idiopathic interstitial pneumonias treated with thrombomodulin 2021 ·BMJ Open Respiratory Research ·Toru Arai, Hiroto Matsuoka, Masaki Hirose, Hiroshi Kida, Suguru Yamamoto, Yoshitaka Ogata, Masahide Mori, (unknown), Chikatoshi Sugimoto, Kazunobu Tachibana, Masanori Akira, Yoshikazu Inoue	3
5	Efficacy of recombinant thrombomodulin for poor prognostic cases of acute exacerbation in idiopathic interstitial pneumonia: secondary analysis of the SETUP trial 2020 ·BMJ Open Respiratory Research ·Toru Arai, Hiroshi Kida, Yoshitaka Ogata, Satoshi Marumo, Hiroto Matsuoka, (unknown), Suguru Yamamoto, Masahide Mori, Chikatoshi Sugimoto, Kazunobu Tachibana, Masanori Akira, Yoshikazu Inoue	4
6	Acute lung injury after plasma exchange in a patient with anti-MDA5 antibody-positive, rapidly progressive, interstitial lung disease：A case report 2020 ·Respiratory Medicine Case Reports ·Hiroyuki Kagawa, Kazuyuki Tsujino, Yuji Yamamoto, (unknown), Reina Hara, Takanori Matsuki, Kiyoharu Fukushima, (unknown), Kenji Yoshimura, Mari Miki, Keisuke Miki, Seigo Kitada, Masahide Mori, Hiroshi Kida	12
7	Diagnostic Validity of Gastric Aspirate Culture in Nontuberculous Mycobacterial Pulmonary Disease 2020 ·Annals of the American Thoracic Society ·Reina Hara, Seigo Kitada, (unknown), Tomoki Kuge, (unknown), Hiroyuki Kagawa, Kazuyuki Tsujino, Kenji Yoshimura, Mari Miki, Keisuke Miki, Hiroshi Kida	2
8	Recombinant thrombomodulin for acute exacerbation in idiopathic interstitial pneumonias 2019 ·Respirology ·Toru Arai, Hiroshi Kida, Yoshitaka Ogata, Satoshi Marumo, Hiroto Matsuoka, (unknown), Suguru Yamamoto, Masahide Mori, Chikatoshi Sugimoto, Kazunobu Tachibana, Masanori Akira, Ryuya Edahiro, Toshimitsu Hamasaki, Yoshikazu Inoue	10
9	Exhaled Breath Analysis for Lung Cancer 2016 ·Journal of the Japan Society for Precision Engineering ·Hiroshi Kida	3
10	HER2 As Therapeutic Target for Overcoming ATP-Binding Cassette Transporter–Mediated Chemoresistance in Small Cell Lung Cancer 2012 ·Molecular Cancer Therapeutics ·Toshiyuki Minami, Takashi Kijima, Yasushi Otani, (unknown), Ryo Takahashi, Izumi Nagatomo, Haruhiko Hirata, Mayumi Suzuki, Koji Inoue, Yoshito Takeda, Hiroshi Kida, Isao Tachibana, Atsushi Kumanogoh	24
11	Early [18F]Fluorodeoxyglucose Positron Emission Tomography at Two Days of Gefitinib Treatment Predicts Clinical Outcome in Patients with Adenocarcinoma of the Lung 2011 ·Clinical Cancer Research ·Ryo Takahashi, Haruhiko Hirata, Isao Tachibana, Eku Shimosegawa, Atsuo Inoue, Izumi Nagatomo, Yoshito Takeda, Hiroshi Kida, Sho Goya, Takashi Kijima, Mitsuhiro Yoshida, Toru Kumagai, Atsushi Kumanogoh, Meinoshin Okumura, Jun Hatazawa, Ichiro Kawase	78
12	Two cases of leptomeningeal metastases from lung adenocarcinoma which progressed during gefitinib therapy but responded to erlotinib 2011 ·International Journal of Clinical Oncology ·Satoshi Tetsumoto, Akio Osa, Takashi Kijima, Toshiyuki Minami, Haruhiko Hirata, Ryo Takahashi, Hanako Kuhara, Izumi Nagatomo, Yoshito Takeda, Hiroshi Kida, Sho Goya, Isao Tachibana, Ichiro Kawase	14
13	Recurrent allergic bronchopulmonary aspergillosis in a patient with rheumatoid arthritis treated with etanercept and tocilizumab 2011 ·Modern Rheumatology ·(unknown), Hiroshi Kida, Mitsuhiro Yoshida, Tetsuya Tomita, (unknown), Shôichi Ihara, Sho Goya, Isao Tachibana, Ichiro Kawase	12
14	Involvement of Endothelial Apoptosis Underlying Chronic Obstructive Pulmonary Disease–like Phenotype in Adiponectin-null Mice: Implications for Therapy 2011 ·American Journal of Respiratory and Critical Care Medicine ·Kaori Nakanishi, Yoshito Takeda, Satoshi Tetsumoto, Takeo Iwasaki, Kazuyuki Tsujino, Hanako Kuhara, Yingji Jin, Izumi Nagatomo, Hiroshi Kida, (unknown), Takashi Kijima, Norikazu Maeda, Tohru Funahashi, Iichiro Shimomura, Isao Tachibana, Ichiro Kawase	57
15	Lingual angioedema after rt-PA thrombolysis for acute cardioembolic stroke: A case report 2010 ·Nosotchu ·Kõji Tanaka, Shoji Matsumoto, Hiroshi Kida, (unknown), Kimihiro Tanaka, Masakazu Kawajiri, Takeshi Yamada	1
16	Tetraspanin CD9 Negatively Regulates Lipopolysaccharide-Induced Macrophage Activation and Lung Inflammation 2009 ·The Journal of Immunology ·Mayumi Suzuki, Isao Tachibana, Yoshito Takeda, Ping He, Seigo Minami, Takeo Iwasaki, Hiroshi Kida, (unknown), Takashi Kijima, Mitsuhiro Yoshida, Toru Kumagai, Tadashi Osaki, Ichiro Kawase	70
17	Protective effect of IL-6 on alveolar epithelial cell death induced by hydrogen peroxide 2004 ·American Journal of Physiology-Lung Cellular and Molecular Physiology ·Hiroshi Kida, Mitsuhiro Yoshida, (unknown), Koji Inoue, Yukihiro Yano, Masahiko Yanagita, Toru Kumagai, Tadashi Osaki, Isao Tachibana, Yukihiko Saeki, Ichiro Kawase	53
18	Pathologic findings of initial biopsies reflect the outcomes of membranous nephropathy 2003 ·Kidney International ·Keiichi Yoshimoto, Hitoshi Yokoyama, Takashi Wada, Kengo Furuichi, Norihiko Sakai, Yasunori Iwata, Satoshi Goshima, Hiroshi Kida	37
19	Two distinct types of crescentic glomerulonephritis. 1992 ·PubMed ·Shin’ichi Takeda, Hiroshi Kida, H. Yokoyama, (unknown), K Kobayashi	10
20	A COMPARATIVE STUDY OF NON-SURGICAL TREATMENT AND SURGICAL TREATMENT OF COMPLETE TEARS OF THE ROTATOR CUFF 1987 ·(unknown), Hiroshi Kida, (unknown), Keiji Masuda	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact